A kit for detecting genetic molecular markers associated with susceptibility to endometrial cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2020-09-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical fields of molecular biology and biomedicine, in particular to a kit for detecting endometrial cancer susceptibility based on the SNP site of the NANOG gene. Background technique
[0002] Endometrial cancer is one of the most common gynecological tumors in the world. Its incidence has been increasing over the past few decades and tends to be younger, especially in developed countries. In recent years, as the global obesity rate has increased, the incidence of endometrial cancer in China has also increased, with 63,400 newly diagnosed cases in 2015. According to the FIGO 2009 classification, 80% of endometrial cancers are clinical stage I-II when diagnosed, the 5-year survival rate of stage I is 89.6%, that of stage II drops to 78.3%, that of stage III is 61.9%, and that of stage IV is 21.1%. Although endometrial cancer diagnosed early can be cured with surgery plus adjuvant radiotherapy or chemotherapy, approxima...